LU-51198

N/A

Report date: 2023/02/12 00:15:54

NME

Base Information

Drug NameLU-51198

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionComplement system proteins inhibitors

TargetsComplement system proteins

Therapy Area/IndicationsMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbbott Gmbh & Co Kg

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsMyocardial Ischemia

ATC CodeN/A